CHI3L1 is gaining increasing attention as a potential biomarker and therapeutic target in inflammation-associated cancers, as summarized in Table 2 [90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,117]. Here, CHI3L1 is linked to cancer.